Forest offers a variety of therapies that can provide a meaningful benefit to people's
lives. Our diverse range of prescription products includes: BYSTOLIC®
(nebivolol), DALIRESP® (roflumilast), LINZESS™ (linaclotide),
NAMENDA® (memantine HCl), SAVELLA® (milnacipran HCl),
TEFLARO® (ceftaroline fosamil) for injection, TUDORZA®
PRESSAIR® (aclidinium bromide inhalation powder), and
VIIBRYD® (vilazodone HCl).
- Healthcare Professionals
-
If you are a healthcare professional and have a question or need information
about a specific Forest product, please contact Forest's Medical Information and
Communication Department at 800-678-1605, extension 66297.
Back to Top
- Consumers
-
If you have questions regarding any Forest product, please contact your healthcare provider.
Back to Top
-
ARMOUR®, BYSTOLIC®,
CELEXA®, CERVIDIL®,
LEVOTHROID®, LEXAPRO®, SAVELLA®,
TEFLARO®, THYROLAR®, and VIIBRYD®
are registered trademarks of Forest Laboratories, Inc.
AEROCHAMBER®, AEROCHAMBER PLUS® and FLOW-VU® are registered trademarks of Trudell Medical International.
CAMPRAL® is a registered trademark of Merck Santé.
DALIRESP® is a registered trademark of Takeda GmbH.
LINZESS™ is a trademark of Ironwood Pharmaceuticals, Inc.
MONUROL® is a registered trademark of Zambon S.p.A.
NAMENDA® is a registered trademark of Merz Pharma GmbH & Co. KGaA.
TIAZAC® is a registered trademark of Valeant International SRL.
TUDORZA® and PRESSAIR® are registered trademarks of Almirall, S.A.
Back to Top